At what price were the KalVista (KALV) shares sold in the tax-related transaction?

The 1,489 KalVista common shares were sold at an average price of $26.7778 per share. According to the filing footnote, this sale was executed to fund tax withholding obligations associated with recently vested RSUs.

KalVista (NASDAQ: KALV) CCO exercises RSUs, sells shares to cover taxes

Filing Impact

(Neutral)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

KalVista Pharmaceuticals’ Chief Commercial Officer Nicole Sweeny reported routine equity compensation activity. On May 22, 2026, she exercised 5,000 Restricted Stock Units (RSUs), each converting into one share of common stock for no cash cost. A Form 4 footnote explains that on May 26, 2026 she sold 1,489 common shares at $26.7778 per share solely to cover tax withholding obligations through a “sell to cover” transaction, which the company notes was not a discretionary sale. After these transactions, she directly holds 59,291 shares of common stock and 40,000 RSUs that continue to vest quarterly, subject to continued service.

Insider Trade Summary

Net Seller: 1,489 shares ($39,872)

Net Sell 3 txns

Insider Sweeny Nicole

Role Chief Commercial Officer

Sold 1,489 shs ($40K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,489	$26.7778	$40K
Exercise	Restricted Stock Unit	5,000	$0.00	--
Exercise	Common Stock	5,000	$0.00	--

Holdings After Transaction: Common Stock — 59,291 shares (Direct, null); Restricted Stock Unit — 40,000 shares (Direct, null)

Footnotes (1)

Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. 1/16th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on August 22, 2024, subject to continued service through each vesting date.

Key Figures

Shares sold to cover taxes: 1,489 shares Sale price per share: $26.7778 per share RSUs exercised: 5,000 RSUs +2 more

5 metrics

Shares sold to cover taxes 1,489 shares Open-market sale on May 26, 2026 at $26.7778 per share

Sale price per share $26.7778 per share Price for 1,489 KalVista common shares sold

RSUs exercised 5,000 RSUs RSUs converted into common stock on May 22, 2026

Common shares held after transactions 59,291 shares Direct KalVista common stock ownership following Form 4 transactions

RSUs outstanding after transactions 40,000 RSUs Restricted Stock Units remaining after 5,000-unit conversion

Key Terms

Restricted Stock Unit, sell to cover, vesting and settlement, Vesting Commencement Date, +1 more

5 terms

Restricted Stock Unit financial

"Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

sell to cover financial

"sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction"

Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.

vesting and settlement financial

"shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs"

Vesting Commencement Date financial

"quarterly anniversary of the Vesting Commencement Date commencing on August 22, 2024"

The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.

contingent right financial

"represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement"

Form 4 Insider Transactions: What Each Field Means →

05/27/2026 - 04:05 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sweeny Nicole

(Last)

(First)

(Middle)

C/O KALVISTA PHARMACEUTICALS, INC.

200 CROSSING BOULEVARD

(Street)

FRAMINGHAM

MASSACHUSETTS

01702

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
KalVista Pharmaceuticals, Inc. [ KALV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Commercial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/22/2026		M		5,000	A	⁽¹⁾	60,780	D
Common Stock	05/26/2026		S⁽²⁾		1,489	D	$26.7778	59,291	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	⁽¹⁾	05/22/2026		M			5,000	⁽³⁾	⁽³⁾	Common Stock	5,000	$0	40,000	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

2. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

3. 1/16th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on August 22, 2024, subject to continued service through each vesting date.

	/s/ Benjamin L. Palleiko, Attorney-in-Fact	05/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did KalVista (KALV) Chief Commercial Officer report?

Nicole Sweeny exercised 5,000 Restricted Stock Units and sold 1,489 common shares. The sale was a “sell to cover” transaction used to satisfy tax withholding obligations tied to the RSU vesting and settlement.

Was the KalVista (KALV) insider stock sale a discretionary transaction?

No. A Form 4 footnote states the 1,489-share sale was executed solely to cover tax withholding obligations from RSU vesting. It clarifies this “sell to cover” does not represent a discretionary transaction by the reporting person.

How many KalVista (KALV) shares does Nicole Sweeny hold after the Form 4?

Following the reported transactions, Nicole Sweeny directly holds 59,291 shares of KalVista common stock. She also holds 40,000 Restricted Stock Units that continue to vest quarterly, subject to her continued service with the company.

How do the KalVista (KALV) RSUs reported in the Form 4 vest over time?

The Form 4 states that 1/16th of the total RSU shares vest on each quarterly anniversary of the August 22, 2024 vesting commencement date. Vesting continues only if the reporting person remains in service through each vesting date.